Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia

BACKGROUND: Methotrexate (MTX) eradicates leukemic cells by disrupting de novo nucleotide biosynthesis and DNA replication, resulting in cell death. Since its introduction in 1947, MTX-containing chemotherapeutic regimens have proven instrumental in achieving curative effects in acute lymphoblastic...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Hematol Oncol
Main Authors: Wojtuszkiewicz, Anna, Peters, Godefridus J., van Woerden, Nicole L., Dubbelman, Boas, Escherich, Gabriele, Schmiegelow, Kjeld, Sonneveld, Edwin, Pieters, Rob, van de Ven, Peter M., Jansen, Gerrit, Assaraf, Yehuda G., Kaspers, Gertjan J. L., Cloos, Jacqueline
格式: Artigo
語言:Inglês
出版: BioMed Central 2015
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4455979/
https://ncbi.nlm.nih.gov/pubmed/26022503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-015-0158-9
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍